Yo, what’s good? My name’s Dan and I’m here to tell you about CaaMTech, a dope company that’s on the cutting edge of mental health research. They got a patent in 2021 for their work developing pharmaceutical drugs to treat depression and obsessive-compulsive disorder, and now they’re looking into the therapeutic value of psilocybin and cannabinoids together.
According to an article on Greenstate, CaaMTech has isolated some sick derivatives of psilocybin, cannabinoids, and terpenes. The founder and CEO, Dr. Andrew Chadeayne, said in the patent announcement that their goal has always been to capture as much of their scientific innovation … Read more “Sci-Fi Cats Tryna Mix Up Shrooms and Mary Jane for One Dope AF Cure”